[Diagnostic progress in testicular carcinoma].
The diagnostic value of the serum tumour markers, beta-HCG and AFP, is investigated in 71 patients with malignant testicular tumours. Regular screening with beta-HCG and AFP, has improved the early diagnosis of recurrences and metastases in nonseminomatous testicular tumours.
D002822:Choriocarcinoma / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D004407:Dysgerminoma / Q000097:blood; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008207:Lymphatic Metastasis; D008297:Male; D011863:Radioimmunoassay; D013724:Teratoma / Q000097:blood; D013736:Testicular Neoplasms / Q000097:blood / Q000175:diagnosis*; D000509:alpha-Fetoproteins / Q000097:blood
D006063:Chorionic Gonadotropin; D000509:alpha-Fetoproteins; D007986:Luteinizing Hormone
Diagnostische Fortschritte bei malignen Hodentumoren.